BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 18463563)

  • 1. Prodrugs for amines.
    Simplício AL; Clancy JM; Gilmer JF
    Molecules; 2008 Mar; 13(3):519-47. PubMed ID: 18463563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel prodrug approach for tertiary amines: synthesis and preliminary evaluation of N-phosphonooxymethyl prodrugs.
    Krise JP; Zygmunt J; Georg GI; Stella VJ
    J Med Chem; 1999 Aug; 42(16):3094-100. PubMed ID: 10447953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide prodrugs: diazeniumdiolate anions of hindered secondary amines.
    Chakrapani H; Showalter BM; Citro ML; Keefer LK; Saavedra JE
    Org Lett; 2007 Oct; 9(22):4551-4. PubMed ID: 17918856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new aliphatic amino prodrug system for the delivery of small molecules and proteins utilizing novel PEG derivatives.
    Greenwald RB; Zhao H; Yang K; Reddy P; Martinez A
    J Med Chem; 2004 Jan; 47(3):726-34. PubMed ID: 14736253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphate-Based Self-Immolative Linkers for the Delivery of Amine-Containing Drugs.
    Đud M; Tichotová M; Procházková E; Baszczyňski O
    Molecules; 2021 Aug; 26(17):. PubMed ID: 34500595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linking bisphosphonates to the free amino groups in fluoroquinolones: preparation of osteotropic prodrugs for the prevention of osteomyelitis.
    Houghton TJ; Tanaka KS; Kang T; Dietrich E; Lafontaine Y; Delorme D; Ferreira SS; Viens F; Arhin FF; Sarmiento I; Lehoux D; Fadhil I; Laquerre K; Liu J; Ostiguy V; Poirier H; Moeck G; Parr TR; Far AR
    J Med Chem; 2008 Nov; 51(21):6955-69. PubMed ID: 18834106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies toward Organic Carbon Monoxide Prodrugs.
    Ji X; Wang B
    Acc Chem Res; 2018 Jun; 51(6):1377-1385. PubMed ID: 29762011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coumarin-based prodrugs. Part 3: Structural effects on the release kinetics of esterase-sensitive prodrugs of amines.
    Wang B; Zhang H; Zheng A; Wang W
    Bioorg Med Chem; 1998 Apr; 6(4):417-26. PubMed ID: 9597186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dipeptidyl peptidase IV (DPPIV/CD26)-based prodrugs of hydroxy-containing drugs.
    Diez-Torrubia A; Cabrera S; Lambeir AM; Balzarini J; Camarasa MJ; Velázquez S
    ChemMedChem; 2012 Apr; 7(4):618-28. PubMed ID: 22307932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel prodrug approach for tertiary amines. 3. In vivo evaluation of two N-phosphonooxymethyl prodrugs in rats and dogs.
    Krise JP; Charman WN; Charman SA; Stella VJ
    J Pharm Sci; 1999 Sep; 88(9):928-32. PubMed ID: 10479356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel prodrug approach for tertiary amines. 2. Physicochemical and in vitro enzymatic evaluation of selected N-phosphonooxymethyl prodrugs.
    Krise JP; Narisawa S; Stella VJ
    J Pharm Sci; 1999 Sep; 88(9):922-7. PubMed ID: 10479355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and preliminary evaluation of gabapentin-pregabalin mutual prodrugs in relieving neuropathic pain.
    Shi W; Liu H; Zhang Y; Zhong B; Yang H
    Arch Pharm (Weinheim); 2005 Aug; 338(8):358-64. PubMed ID: 16041834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of water-soluble prodrugs of the HIV-1 protease inhibitor KNI-727: importance of the conversion time for higher gastrointestinal absorption of prodrugs based on spontaneous chemical cleavage.
    Sohma Y; Hayashi Y; Ito T; Matsumoto H; Kimura T; Kiso Y
    J Med Chem; 2003 Sep; 46(19):4124-35. PubMed ID: 12954064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aliphatic amines are viable pro-drug moieties in phosphonoamidate drugs.
    Yan VC; Pham CD; Arthur K; Yang KL; Muller FL
    Bioorg Med Chem Lett; 2020 Dec; 30(24):127656. PubMed ID: 33130289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and evaluation of novel cyclic phosphates of 5-aminosalicylic acid as cytochrome p450-activated prodrugs.
    Huttunen KM; Tani N; Juvonen RO; Raunio H; Rautio J
    Mol Pharm; 2013 Feb; 10(2):532-7. PubMed ID: 22937971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, stability and in vitro dermal evaluation of aminocarbonyloxymethyl esters as prodrugs of carboxylic acid agents.
    Mendes E; Furtado T; Neres J; Iley J; Jarvinen T; Rautio J; Moreira R
    Bioorg Med Chem; 2002 Mar; 10(3):809-16. PubMed ID: 11814870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphonate prodrugs: an overview and recent advances.
    Heidel KM; Dowd CS
    Future Med Chem; 2019 Jul; 11(13):1625-1643. PubMed ID: 31469328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective treatment of hypoxic tumor cells in vivo: phosphate pre-prodrugs of nitro analogues of the duocarmycins.
    Tercel M; Atwell GJ; Yang S; Ashoorzadeh A; Stevenson RJ; Botting KJ; Gu Y; Mehta SY; Denny WA; Wilson WR; Pruijn FB
    Angew Chem Int Ed Engl; 2011 Mar; 50(11):2606-9. PubMed ID: 21370347
    [No Abstract]   [Full Text] [Related]  

  • 19. Click and Release: A Chemical Strategy toward Developing Gasotransmitter Prodrugs by Using an Intramolecular Diels-Alder Reaction.
    Ji X; Zhou C; Ji K; Aghoghovbia RE; Pan Z; Chittavong V; Ke B; Wang B
    Angew Chem Int Ed Engl; 2016 Dec; 55(51):15846-15851. PubMed ID: 27879021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress towards bioorthogonal catalysis with organometallic compounds.
    Völker T; Dempwolff F; Graumann PL; Meggers E
    Angew Chem Int Ed Engl; 2014 Sep; 53(39):10536-40. PubMed ID: 25138780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.